Mapping the interaction between high molecular mass kininogen and the urokinase plasminogen activator receptor

被引:36
|
作者
Mahdi, F
Shariat-Madar, Z
Kuo, A
Carinato, M
Cines, DB
Schmaier, AH
机构
[1] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA
[3] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA
[4] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA
关键词
D O I
10.1074/jbc.M313850200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The urokinase plasminogen activator receptor (uPAR) is a multifunctional, GPI-linked receptor that modulates cell adhesion/migration and fibrinolysis. We mapped the interaction sites between soluble uPAR (suPAR) and high molecular mass kininogen (HK). Binding of biotin-HK to suPAR was inhibited by HK, 56HKa, and 46HKa with an IC50 of 60, 110, and 8 nM, respectively. We identified two suPAR-binding sites, a higher affinity site in the light chain of HK and 46HKa (His(477)-Gly(496)) and a lower affinity site within the heavy chain (Cys(333)-Lys(345)). HK predominantly bound to suPAR fragments containing domains 2 and 3 (S-D2D3). Binding of HK to domain 1 (S-D1) was also detected, and the addition of S-D1 to S-D2D3 completely inhibited biotin-HK or -46HKa binding to suPAR. Using sequential and overlapping 20-amino acid peptides prepared from suPAR, two regions for HK binding were identified. One on the carboxyl-terminal end of D2 (Leu(166)-Thr(195)) blocked HK binding to suPAR and to human umbilical vein endothelial cells (HUVEC). This site overlapped with the urokinase-binding region, and urokinase inhibited the binding of HK to suPAR. A second region on the amino-terminal portion of D3 (Gln(215)-Asn(255))also blocked HK binding to HUVEC. Peptides that blocked HK binding to uPAR also inhibited prekallikrein activation on HUVEC. Therefore, HK interacts with suPAR at several sites. HK binds to uPAR as part of its interaction with its multiprotein receptor complex on HUVEC, and the biological functions that depend upon this binding are modulated by urokinase.
引用
收藏
页码:16621 / 16628
页数:8
相关论文
共 50 条
  • [31] Identification of urokinase plasminogen activator (uPA) and urokinase plasminogen activator receptor (uPAR) as therapeutic targets for pancreatic cancer.
    Della Croce, K
    Han, H
    Beroza, P
    Bearss, DJ
    von Hoff, DD
    CLINICAL CANCER RESEARCH, 2001, 7 (11) : 3668S - 3668S
  • [32] Serum soluble urokinase plasminogen activator receptor in adolescents: interaction of chronic pain and obesity
    Raff, Hershel
    Phillips, Jonathan M.
    Simpson, Pippa M.
    Weisman, Steven J.
    Hainsworth, Keri R.
    PAIN REPORTS, 2020, 5 (04)
  • [33] REGULATION OF THE UROKINASE RECEPTOR BY ITS PLASMINOGEN-ACTIVATOR
    HOLLAS, W
    BOYD, D
    THROMBOSIS AND HAEMOSTASIS, 1991, 66 (06) : 678 - 683
  • [34] Intermolecular contact regions in urokinase plasminogen activator receptor
    Liang, OD
    Bdeir, K
    Matz, RL
    Chavakis, T
    Preissner, KT
    JOURNAL OF BIOCHEMISTRY, 2003, 134 (05): : 661 - 666
  • [35] The role of the Urokinase Plasminogen Activator Receptor in severe asthma
    Moseley, C.
    Rankin, G.
    Sayersw, I.
    Howarth, P. H.
    Warner, J. A.
    Holloway, J. W.
    CLINICAL AND EXPERIMENTAL ALLERGY, 2011, 41 (12): : 1828 - 1829
  • [36] Elevated urokinase-specific surface receptor expression is maintained through its interaction with urokinase plasminogen activator
    Mahanivong, Chitladda
    Yu, Jianqiang
    Huang, Shuang
    MOLECULAR CARCINOGENESIS, 2007, 46 (03) : 165 - 175
  • [37] Measurement of soluble urokinase plasminogen activator receptor in serum
    Riisbro, R
    Piironen, T
    Brünner, N
    Larsen, B
    Nielsen, HJ
    Stephens, RW
    Hoyer-Hansen, G
    JOURNAL OF CLINICAL LIGAND ASSAY, 2002, 25 (01): : 53 - 56
  • [38] Dietary predictors of circulating urokinase plasminogen activator receptor
    Drake, I.
    Schulz, C. A.
    Ericson, U.
    Nilsson, J.
    Melander, O.
    Engstrom, G.
    Orho-Melander, M.
    DIABETOLOGIA, 2016, 59 : S52 - S52
  • [39] Crystal structure of the human urokinase plasminogen activator receptor
    Llinas, P
    Le Du, MH
    Gårdsvoll, H
    Dano, K
    Gilquin, B
    Stura, EA
    Ménez, A
    Ploug, M
    THROMBOSIS AND HAEMOSTASIS, 2005, 93 (04) : A8 - A8
  • [40] Tristetraprolin Inhibits the Growth of Human Glioma Cells through Downregulation of Urokinase Plasminogen Activator/Urokinase Plasminogen Activator Receptor mRNAs
    Ryu, Jinhyun
    Yoon, Nal Ae
    Lee, Yeon Kyung
    Jeong, Joo Yeon
    Kang, Seokmin
    Seong, Hyemin
    Choi, Jungil
    Park, Nammi
    Kim, Nayoung
    Cho, Wha Ja
    Paek, Sun Ha
    Cho, Gyeong Jae
    Choi, Wan Sung
    Park, Jae-Yong
    Park, Jeong Woo
    Kang, Sang Soo
    MOLECULES AND CELLS, 2015, 38 (02) : 156 - 162